Kisoji Biotechnology
United States · $41.0M raised
- Business Model
- B2B
- Website
- kisojibiotech.com
- Total Funding
- $41.0M
- Last Round
- $41.0M Series BDec 2024
- Rounds
- 1
About
Antibody therapeutics company developing next-generation multi-specific antibody technologies for oncology.
Summary
Kisoji Biotechnology is a Biotech company based in United States. It has raised $41.0M in total across 1 round, most recently a $41.0M Series B round in Dec 2024. Investors include Investissement Quebec and Lumira Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company